RDY Accounts Payable vs Net Debt Analysis

RDY Stock  USD 14.40  0.06  0.41%   
Dr Reddys financial indicator trend analysis is much more than just examining Dr Reddys Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dr Reddys Laboratories is a good investment. Please check the relationship between Dr Reddys Accounts Payable and its Net Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Accounts Payable vs Net Debt

Accounts Payable vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dr Reddys Laboratories Accounts Payable account and Net Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Dr Reddys' Accounts Payable and Net Debt is 0.98. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Debt in the same time period over historical financial statements of Dr Reddys Laboratories, assuming nothing else is changed. The correlation between historical values of Dr Reddys' Accounts Payable and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Dr Reddys Laboratories are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Accounts Payable i.e., Dr Reddys' Accounts Payable and Net Debt go up and down completely randomly.

Correlation Coefficient

0.98
Relationship DirectionPositive 
Relationship StrengthVery Strong

Accounts Payable

An accounting item on the balance sheet that represents Dr Reddys obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Dr Reddys Laboratories are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Dr Reddys' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, Dr Reddys' Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 845.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 73.3 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit113.8B203.0B163.6B171.8B
Total Revenue214.4B245.9B279.2B293.1B

Dr Reddys fundamental ratios Correlations

0.970.990.96-0.060.990.54-0.14-0.140.911.00.990.910.98-0.160.95-0.20.99-0.050.960.990.880.951.00.980.27
0.970.960.990.130.950.460.0-0.180.950.980.940.880.93-0.010.88-0.140.950.070.90.960.930.970.970.960.33
0.990.960.94-0.141.00.57-0.18-0.160.880.991.00.90.99-0.220.98-0.231.0-0.110.970.990.850.930.990.990.24
0.960.990.940.190.940.450.0-0.150.970.960.930.870.910.040.86-0.110.940.070.880.950.950.980.950.950.35
-0.060.13-0.140.19-0.15-0.360.680.090.21-0.03-0.180.04-0.220.87-0.310.52-0.140.7-0.27-0.070.220.13-0.08-0.120.41
0.990.951.00.94-0.150.56-0.23-0.130.890.991.00.90.99-0.240.98-0.251.0-0.160.980.990.870.930.990.990.23
0.540.460.570.45-0.360.56-0.45-0.310.50.510.590.320.6-0.490.63-0.40.57-0.380.490.520.360.540.560.570.43
-0.140.0-0.180.00.68-0.23-0.450.12-0.12-0.1-0.230.01-0.270.8-0.330.64-0.20.85-0.28-0.13-0.12-0.13-0.15-0.20.2
-0.14-0.18-0.16-0.150.09-0.13-0.310.12-0.24-0.15-0.130.19-0.160.4-0.110.59-0.130.07-0.06-0.08-0.26-0.24-0.18-0.150.1
0.910.950.880.970.210.890.5-0.12-0.240.910.880.770.87-0.010.81-0.20.89-0.010.810.890.980.990.910.910.34
1.00.980.990.96-0.030.990.51-0.1-0.150.910.980.90.97-0.140.94-0.210.99-0.010.950.990.880.950.990.980.26
0.990.941.00.93-0.181.00.59-0.23-0.130.880.980.891.0-0.260.99-0.261.0-0.160.980.990.840.920.990.990.24
0.910.880.90.870.040.90.320.010.190.770.90.890.860.080.860.150.90.030.90.940.750.80.890.880.31
0.980.930.990.91-0.220.990.6-0.27-0.160.870.971.00.86-0.310.99-0.30.99-0.210.980.980.840.920.980.990.23
-0.16-0.01-0.220.040.87-0.24-0.490.80.4-0.01-0.14-0.260.08-0.31-0.370.85-0.220.66-0.31-0.140.01-0.07-0.19-0.220.29
0.950.880.980.86-0.310.980.63-0.33-0.110.810.940.990.860.99-0.37-0.310.98-0.270.990.960.770.860.960.970.19
-0.2-0.14-0.23-0.110.52-0.25-0.40.640.59-0.2-0.21-0.260.15-0.30.85-0.31-0.230.39-0.26-0.15-0.19-0.24-0.23-0.240.24
0.990.951.00.94-0.141.00.57-0.2-0.130.890.991.00.90.99-0.220.98-0.23-0.140.980.990.860.930.990.990.25
-0.050.07-0.110.070.7-0.16-0.380.850.07-0.01-0.01-0.160.03-0.210.66-0.270.39-0.14-0.22-0.07-0.05-0.03-0.07-0.130.19
0.960.90.970.88-0.270.980.49-0.28-0.060.810.950.980.90.98-0.310.99-0.260.98-0.220.970.80.860.960.970.14
0.990.960.990.95-0.070.990.52-0.13-0.080.890.990.990.940.98-0.140.96-0.150.99-0.070.970.860.930.990.990.27
0.880.930.850.950.220.870.36-0.12-0.260.980.880.840.750.840.010.77-0.190.86-0.050.80.860.960.870.880.22
0.950.970.930.980.130.930.54-0.13-0.240.990.950.920.80.92-0.070.86-0.240.93-0.030.860.930.960.940.940.33
1.00.970.990.95-0.080.990.56-0.15-0.180.910.990.990.890.98-0.190.96-0.230.99-0.070.960.990.870.940.990.27
0.980.960.990.95-0.120.990.57-0.2-0.150.910.980.990.880.99-0.220.97-0.240.99-0.130.970.990.880.940.990.26
0.270.330.240.350.410.230.430.20.10.340.260.240.310.230.290.190.240.250.190.140.270.220.330.270.26
Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets232.2B265.5B296.7B322.9B387.5B214.9B
Other Current Liab39.4B45.3B48.3B53.5B58.1B61.0B
Total Current Liabilities72.8B81.5B97.8B85.7B96.0B69.8B
Total Stockholder Equity155.0B175.0B190.5B232.9B280.6B294.6B
Retained Earnings144.2B157.9B175.7B215.6B265.3B278.5B
Accounts Payable10.7B12.7B16.0B17.9B21.5B14.3B
Cash2.1B14.8B14.9B5.8B7.1B13.6B
Other Assets14.8B11.6B13.7B7.1B8.2B8.6B
Long Term Debt21.4B0.06.3B5.7B3.8B3.5B
Short Term Investments23.7B19.7B29.5B61.0B74.4B78.1B
Inventory35.1B45.4B50.9B48.7B63.6B32.0B
Total Liab77.3B90.5B106.1B90.0B107.0B89.6B
Intangible Assets27.7B35.6B27.2B30.7B37.0B24.7B
Property Plant Equipment52.3B57.1B62.2B66.3B76.2B80.1B
Short Long Term Debt Total22.1B30.3B33.8B13.5B20.0B19.0B
Other Liab3.5B3.1B2.7B2.5B2.9B3.1B
Property Plant And Equipment Net52.3B57.1B62.2B56.5B76.9B55.3B
Current Deferred Revenue1.9B2.0B2.6B2.0B1.4B1.4B
Net Debt20.0B15.5B19.0B7.7B12.9B12.3B
Non Current Assets Total101.9B117.2B115.5B118.6B139.5B98.4B
Non Currrent Assets Other2.6B952M948M12.7B16.1B16.9B
Cash And Short Term Investments25.7B34.6B44.4B66.7B81.5B85.5B
Net Receivables61.8B49.6B66.8B72.5B80.3B48.4B
Good Will4.0B4.6B4.4B5.5B4.3B6.5B
Common Stock Shares Outstanding166.1M166.3M166.3M166.4M166.7M175.5M
Liabilities And Stockholders Equity232.2B265.5B296.7B322.9B387.5B223.8B
Non Current Liabilities Total4.4B9.0B8.3B4.3B10.9B20.2B
Other Current Assets5.8B18.6B19.8B21.3B22.7B23.9B
Other Stockholder Equity7.5B8.2B8.4B10.3B10.4B9.0B
Total Current Assets130.4B148.2B181.1B204.3B248.0B127.1B
Accumulated Other Comprehensive Income2.4B1.3B1.1B1.3B4.0B3.8B
Short Term Debt20.8B24.0B28.1B12.2B14.0B27.0B
Property Plant And Equipment Gross52.3B57.1B142.0B152.3B170.1B161.6B
Net Tangible Assets91.9B123.3B134.8B158.9B182.7B102.9B
Long Term Investments3.1B8.3B8.0B6.1B5.3B4.6B
Short Long Term Debt20.3B24.0B28.1B12.2B12.7B16.6B
Long Term Debt Total1.3B6.3B5.7B1.3B1.2B1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.